0000950170-24-076183.txt : 20240621 0000950170-24-076183.hdr.sgml : 20240621 20240621160004 ACCESSION NUMBER: 0000950170-24-076183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240620 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shapiro David CENTRAL INDEX KEY: 0001559570 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39655 FILM NUMBER: 241060038 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES ST. CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galecto, Inc. CENTRAL INDEX KEY: 0001800315 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 371957007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 45-70-70-52-10 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Galecto Inc. DATE OF NAME CHANGE: 20200116 4 1 ownership.xml 4 X0508 4 2024-06-20 0001800315 Galecto, Inc. GLTO 0001559570 Shapiro David OLE MAALOES VEJ 3 C/O GALECTO, INC. COPENHAGEN N G7 G7 DK-2200 DENMARK true false false false false Stock Option (right to buy) 0.49 2024-06-20 4 A false 18000 0 A 2034-06-19 Common Stock 18000 18000 D Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 20, 2024, the date of the Issuer's 2024 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date. /s/ Jonathan Freve, attorney-in-fact 2024-06-21